ProCE Banner Series

Conference to Clinic: Expert Analysis of the Top Abstracts From the 2023 Oncology Meeting in Chicago

Join us for this live, interactive webinar to hear experts discuss some of the most impactful abstracts presented during the ASCO Annual meeting and answer audience questions on the data. Full details on the available topics are provided below.

To Register: Please click the green “Learn More” button below. On the next page, select Register for Virtual Event. Once registered, you will receive a confirmation email. Follow-up emails with event details will be sent as the event nears.

  AMA
Who Should Attend

This program is intended for physicians and other healthcare professionals caring for patients with cancer.

All Events

Conference to Clinic: Expert Analysis of the Top Abstracts From the 2023 Oncology Meeting in Chicago

Past Events

June

17

2023

8:00 AM - 2:55 PM Eastern Time (ET)

Virtual

Faculty

Topics

Conference to Clinic Live Virtual Webinar
Please note: All times are ET

8:05 am – 8:40 am: Gynecologic Malignancies - Lauren Prescott, MD

8:40 am – 9:25 am: Breast Cancer - Sara Tolaney, MD

9:25 – 10:25 am: Non-Accredited Educational Session:
Real World Case Discussion: Intervene with Jakafi® (Ruxolitinib) at Diagnosis in Adults with Intermediate-Risk or High-Risk Myleofibrosis - Leland Metheny, MD
Sponsored by Incyte Corporation

10:25 am – 12:00 pm: Hematologic Malignancies - Eunice Wang, MD; Jeff Sharman, MD; Shaji Kumar, MD

12:00 pm – 1:00 pm: Non-Accredited Educational Session:
Calquence - A BTKi for the Treatment of CLL/SLL with Updated Clinical Trial Data and Tablet Formulation - Catherine Callaghan Coombs, MD
Sponsored by AstraZeneca

1:00 pm – 1:45 pm: Lung Cancer - Heather A. Wakelee, MD

1:45 pm – 2:15 pm: Gastrointestinal Malignancies - Rachna Shroff, MD

2:15 pm – 2:55 pm: Melanoma and other Skin Cancers - Jeffrey Weber, MD

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ understanding of how to optimally apply recent practice-changing findings in treating patients with (Breast, Gastrointestinal, Gynecologic, Hematologic, Lung, Skin) cancer. 

Target Audience
This program is intended for physicians and other healthcare professionals caring for patients with cancer.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify subpopulations of patients with (Breast, Gastrointestinal, Gynecologic, Hematologic, Lung, Skin) cancer most likely to benefit from a specific treatment plan based on predictive biomarkers
  • Apply recently presented data to clinical practice to expand treatment options and improve outcomes for patients with (Breast, Gastrointestinal, Gynecologic, Hematologic, Lung, Skin) cancer
  • Evaluate new data on novel agents and therapeutic approaches for patients with (Breast, Gastrointestinal, Gynecologic, Hematologic, Lung, Skin) cancer

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.75 Gynecologic Malignancies
  • 0.75 Breast Cancer
  • 1.50 Hematologic Malignancies
  • 0.75 Lung Cancer
  • 0.50 Gastrointestinal Malignancies
  • 0.75 Melanoma/Other Skin Cancers

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by educational grants from AbbVie, AstraZeneca, Daiichi Sankyo, Geron, Gilead, GSK, Jazz Pharmaceuticals, Lilly, Merck Sharp & Dohme Corp, Novartis, Novocure, Regeneron Pharmaceuticals, Inc., and Seagen.